1.Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Perez-Paredes C, Barrero-Almodovar AE, Gili-Miner M: Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2001, 33(7):939–946.
2.Fournier PE, Richet H, Weinstein RA: The epidemiology and control of Acinetobacter baumannii in health care facilities. Clinical infectious diseases 2006, 42(5):692–699.
3.Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV: Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. Journal of clinical microbiology 2007, 45(10):3352–3359.
4.Bonomo RA, Szabo D: Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clinical infectious diseases 2006, 43(Supplement_2):S49-S56.
5.Gales AC, Jones R, Sader HS: Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004). Clinical microbiology and infection 2006, 12(4):315–321.
6.Urban C, Mariano N, Rahal JJ, Tay E, Ponio C, Koprivnjak T, Weiss J: Polymyxin B-Resistant Acinetobacter baumanniiClinical Isolate Susceptible to Recombinant BPI21 and Cecropin P1. Antimicrobial agents and chemotherapy 2001, 45(3):994–995.
7.Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S et al: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. The Lancet Infectious diseases 2010, 10(9):597–602.
8.Solomkin JS, Ramesh MK, Cesnauskas G, Novikovs N, Stefanova P, Sutcliffe JA, Walpole SM, Horn PT: Phase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infections. Antimicrob Agents Chemother 2014, 58(4):1847–1854.
9.Sutcliffe JA, O’Brien W, Fyfe C, Grossman TH: Antibacterial activity of eravacycline (TP–434), a novel fluorocycline, against hospital and community pathogens. Antimicrob Agents Chemother 2013, 57(11):5548–5558.
10.Solomkin J, Evans D, Slepavicius A, Lee P, Marsh A, Tsai L, Sutcliffe JA, Horn P: Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial. JAMA surgery 2017, 152(3):224–232.
11.Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, Quale J: Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City. Antimicrobial agents and chemotherapy 2015, 59(3):1802–1805.
12.Monogue ML, Thabit AK, Hamada Y, Nicolau DP: Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms. Antimicrobial agents and chemotherapy 2016, 60(8):5001–5005.
13.Jones-Dias D, Carvalho AS, Moura IB, Manageiro V, Igrejas G, Canica M, Matthiesen R: Quantitative proteome analysis of an antibiotic resistant Escherichia coli exposed to tetracycline reveals multiple affected metabolic and peptidoglycan processes. Journal of proteomics 2017, 156:20–28.
14.Kulkarni HM, Jagannadham MV: Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria. Microbiology 2014, 160(10):2109–2121.
15.Yun SH, Park EC, Lee SY, Lee H, Choi CW, Yi YS, Ro HJ, Lee JC, Jun S, Kim HY et al: Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain, Acinetobacter baumannii DU202. Clinical proteomics 2018, 15:28.
16.Nhu NTK, Riordan DW, Nhu TDH, Thanh DP, Thwaites G, Lan NPH, Wren BW, Baker S, Stabler RA: The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications. Scientific reports 2016, 6:28291.
17.Chen X, Meng X, Gao Q, Zhang G, Gu H, Guo X: Meropenem selection induced overproduction of the intrinsic carbapenemase as well as phenotype divergence in Acinetobacter baumannii. International journal of antimicrobial agents 2017, 50(3):419–426.
18.Yun S-H, Choi C-W, Park S-H, Lee JC, Leem S-H, Choi J-S, Kim S, Kim SI: Proteomic analysis of outer membrane proteins from Acinetobacter baumannii DU202 in tetracycline stress condition. The Journal of Microbiology 2008, 46(6):720–727.
19.Young MD, Wakefield MJ, Smyth GK, Oshlack A: Gene ontology analysis for RNA-seq: accounting for selection bias. Genome biology 2010, 11(2):R14.
20.Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M: The KEGG resource for deciphering the genome. Nucleic Acids Research 2004, 32(suppl_1):D277-D280.
21.Schwechheimer C, Kuehn MJ: Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nature reviews Microbiology 2015, 13(10):605–619.
22.Bhatia VN, Perlman DH, Costello CE, McComb ME: Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Analytical chemistry 2009, 81(23):9819–9823.
23.Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH: Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Frontiers in cellular and infection microbiology 2017, 7:55.
24.Green ER, Mecsas J: Bacterial Secretion Systems: An Overview. Microbiol Spectr 2016, 4(1).
25.Davenport KW, Daligault HE, Minogue TD, Bruce DC, Chain PS, Coyne SR, Jaissle JG, Koroleva GI, Ladner JT, Li P-E: Draft genome assembly of Acinetobacter baumannii ATCC 19606. Genome announcements 2014, 2(4).
26.Sutcliffe J, O’Brien W, Fyfe C, Grossman T: Antibacterial activity of eravacycline (TP–434), a novel fluorocycline, against hospital and community pathogens. Antimicrobial agents and chemotherapy 2013, 57(11):5548–5558.
27.Zhang T, Wang M, Xie Y, Li X, Dong Z, Liu Y, Wang L, Yang M, Song H, Cao H: Active efflux pump adeB is involved in multidrug resistance of Acinetobacter baumannii induced by antibacterial agents. Experimental and therapeutic medicine 2017, 13(4):1538–1546.
28.Coyne S, Courvalin P, Périchon B: Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrobial agents and chemotherapy 2011, 55(3):947–953.
29.Zheng J-x, Lin Z-w, Sun X, Lin W-h, Chen Z, Wu Y, Qi G-b, Deng Q-w, Qu D, Yu Z-j: Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae. Emerging microbes & infections 2018, 7(1):1–11.
30.Bhattacharya M, Toth M, Antunes NT, Smith CA, Vakulenko SB: Structure of the extended-spectrum class C β-lactamase ADC–1 from Acinetobacter baumannii. Acta Crystallographica Section D: Biological Crystallography 2014, 70(3):760–771.
31.Rumbo C, Fernandez-Moreira E, Merino M, Poza M, Mendez JA, Soares NC, Mosquera A, Chaves F, Bou G: Horizontal transfer of the OXA–24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii. Antimicrob Agents Chemother 2011, 55(7):3084–3090.
32.Kulkarni HM, Nagaraj R, Jagannadham MV: Protective role of E. coli outer membrane vesicles against antibiotics. Microbiol Res 2015, 181:1–7.
33.Lee J, Lee EY, Kim SH, Kim DK, Park KS, Kim KP, Kim YK, Roh TY, Gho YS: Staphylococcus aureus extracellular vesicles carry biologically active beta-lactamase. Antimicrob Agents Chemother 2013, 57(6):2589–2595.
34.Roberts MC: Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 2005, 245(2):195–203.
35.Ross W, Vrentas CE, Sanchez-Vazquez P, Gaal T, Gourse RL: The magic spot: a ppGpp binding site on E. coli RNA polymerase responsible for regulation of transcription initiation. Molecular cell 2013, 50(3):420–429.
36.Liu L, Cui Y, Zheng B, Jiang S, Yu W, Shen P, Ji J, Li L, Qin N, Xiao Y: Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach. Sci Rep 2016, 6:26930.
37.Vaara M: Agents that increase the permeability of the outer membrane. Microbiology and Molecular Biology Reviews 1992, 56(3):395–411.
38.Lin X-M, Yang J-N, Peng X-X, Li H: A novel negative regulation mechanism of bacterial outer membrane proteins in response to antibiotic resistance. Journal of proteome research 2010, 9(11):5952–5959.
39.Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, Dao P, Sahinalp SC, Ester M, Foster LJ: PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 2010, 26(13):1608–1615.
40.Jan AT: Outer membrane vesicles (OMVs) of Gram-negative bacteria: a perspective update. Frontiers in microbiology 2017, 8:1053.
41.Kim SW, Park SB, Im SP, Lee JS, Jung JW, Gong TW, Lazarte JMS, Kim J, Seo J-S, Kim J-H: Outer membrane vesicles from β-lactam-resistant Escherichia coli enable the survival of β-lactam-susceptible E. coli in the presence of β-lactam antibiotics. Scientific reports 2018, 8(1):5402.
42.Ciofu O, Beveridge TJ, Kadurugamuwa J, Walther-Rasmussen J, Høiby N: Chromosomal β-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 2000, 45(1):9–13.
43.Manning AJ, Kuehn MJ: Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC microbiology 2011, 11(1):258.
44.Bingle LE, Bailey CM, Pallen MJ: Type VI secretion: a beginner’s guide. Curr Opin Microbiol 2008, 11(1):3–8.
45.Coulthurst SJ: The Type VI secretion system - a widespread and versatile cell targeting system. Res Microbiol 2013, 164(6):640–654.
46.Kapitein N, Mogk A: Deadly syringes: type VI secretion system activities in pathogenicity and interbacterial competition. Curr Opin Microbiol 2013, 16(1):52–58.
47.Chen J, Xie J: Role and regulation of bacterial LuxR-like regulators. J Cell Biochem 2011, 112(10):2694–2702.
48.Cooperman BS, Wooten T, Romero DP, Traut RR: Histidine 229 in protein L2 is apparently essential for 50S peptidyl transferase activity. Biochemistry and cell biology = Biochimie et biologie cellulaire 1995, 73(11–12):1087–1094.
49.Wintermeyer W, Savelsbergh A, Konevega AL, Peske F, Katunin VI, Semenkov YP, Fischer N, Stark H, Rodnina MV: Functions of elongation factor G in translocation and ribosome recycling. In: Ribosomes. Springer; 2011: 329–338.
50.Yoon SH, Park YK, Kim JF: PAIDB v2.0: exploration and analysis of pathogenicity and resistance islands. Nucleic Acids Res 2015, 43(Database issue):D624–630.
51.Kikuchi H, Kim S, Watanabe K, Watarai M: Brucella abortusd-alanyl-D-alanine carboxypeptidase contributes to its intracellular replication and resistance against nitric oxide. FEMS Microbiol Lett 2006, 259(1):120–125.
52.Paixao AC, Ferreira AC, Fontes M, Themudo P, Albuquerque T, Soares MC, Fevereiro M, Martins L, Correa de Sa MI: Detection of virulence-associated genes in pathogenic and commensal avian Escherichia coli isolates. Poultry science 2016, 95(7):1646–1652.
53.Wright MS, Haft DH, Harkins DM, Perez F, Hujer KM, Bajaksouzian S, Benard MF, Jacobs MR, Bonomo RA, Adams MD: New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis. MBio 2014, 5(1):e00963–00913.
54.Luthje P, Brauner A: Virulence factors of uropathogenic E. coli and their interaction with the host. Advances in microbial physiology 2014, 65:337–372.
55.Delepelaire P: Type I secretion in gram-negative bacteria. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 2004, 1694(1–3):149–161.
56.Widjaja M, Harvey KL, Hagemann L, Berry IJ, Jarocki VM, Raymond BBA, Tacchi JL, Gründel A, Steele JR, Padula MP: Elongation factor Tu is a multifunctional and processed moonlighting protein. Scientific reports 2017, 7(1):11227.
57.Pérez-Varela M, Corral J, Aranda J, Barbé J: Functional characterization of AbaQ, a novel efflux pump mediating quinolone resistance in Acinetobacter baumannii. Antimicrobial agents and chemotherapy 2018, 62(9):e00906–00918.
58.Vila J, Martí S, Sanchez-Céspedes J: Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. Journal of antimicrobial chemotherapy 2007, 59(6):1210–1215.
59.Ramos JL, Martínez-Bueno M, Molina-Henares AJ, Terán W, Watanabe K, Zhang X, Gallegos MT, Brennan R, Tobes R: The TetR family of transcriptional repressors. Microbiol Mol Biol Rev 2005, 69(2):326–356.
60.Leus IV, Weeks JW, Bonifay V, Smith L, Richardson S, Zgurskaya HI: Substrate specificities and efflux efficiencies of RND efflux pumps of Acinetobacter baumannii. Journal of bacteriology 2018, 200(13):e00049–00018.
61.Yang H, Huang L, Barnie PA, Su Z, Mi Z, Chen J, Aparna V, Kumar D, Xu H: Characterization and distribution of drug resistance associated β-lactamase, membrane porin and efflux pump genes in MDR A. baumannii isolated from Zhenjiang, China. International journal of clinical and experimental medicine 2015, 8(9):15393.
62.Okada U, Yamashita E, Neuberger A, Morimoto M, van Veen HW, Murakami S: Crystal structure of tripartite-type ABC transporter MacB from Acinetobacter baumannii. Nature communications 2017, 8(1):1336.
63.Lin M-F, Lin Y-Y, Tu C-C, Lan C-Y: Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance. Journal of Microbiology, Immunology and Infection 2017, 50(2):224–231.
64.Fernández L, Hancock RE: Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clinical microbiology reviews 2012, 25(4):661–681.
65.McConnell MJ, Rumbo C, Bou G, Pachón J: Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 2011, 29(34):5705–5710.
66.Kulkarni HM, Nagaraj R, Jagannadham MV: Protective role of E. coli outer membrane vesicles against antibiotics. Microbiological research 2015, 181:1–7.
67.Sjöström AE, Sandblad L, Uhlin BE, Wai SN: Membrane vesicle-mediated release of bacterial RNA. Scientific reports 2015, 5:15329.
68.Sun N, Pan C, Nickell S, Mann M, Baumeister W, Nagy I: Quantitative proteome and transcriptome analysis of the archaeon Thermoplasma acidophilum cultured under aerobic and anaerobic conditions. Journal of proteome research 2010, 9(9):4839–4850.
69.Lin M-F, Lin Y-Y, Lan C-Y: Induction of Tigecycline Resistance in Acinetobacter baumannii. BMC Microbiology 2014.
70.Boinett CJ, Cain AK, Hawkey J, Do Hoang NT, Khanh NNT, Thanh DP, Dordel J, Campbell JI, Lan NPH, Mayho M: Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii. Microbial genomics 2019, 5(2).
71.Chang K-C, Kuo H-Y, Tang CY, Chang C-W, Lu C-W, Liu C-C, Lin H-R, Chen K-H, Liou M-L: Transcriptome profiling in imipenem-selected Acinetobacter baumannii. BMC genomics 2014, 15(1):815.
72.Zhang QS, Ye C, Yang X: Anti-outer membrane vesicle antibodies increase antibiotic sensitivity of pan-drug-resistant Acinetobacter baumannii. Frontiers in Microbiology 2019, 10:1379.
73.Jin JS, Kwon S-O, Moon DC, Gurung M, Lee JH, Kim SI, Lee JC: Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PloS one 2011, 6(2):e17027.
74.Kalli A, Hess S: Effect of mass spectrometric parameters on peptide and protein identification rates for shotgun proteomic experiments on an LTQ‐orbitrap mass analyzer. Proteomics 2012, 12(1):21–31.
75.Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P et al: The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011, 39(Database issue):D561–568.
76.O’Driscoll P, Merenyi E, Karmonik C, Grossman R: SOM and MCODE methods of defining functional clusters in MRI of the brain. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference 2014, 2014:734–737.
77.Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pages F, Trajanoski Z, Galon J: ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009, 25(8):1091–1093.
78.Bindea G, Galon J, Mlecnik B: CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics 2013, 29(5):661–663.